Milestone Scientific shares surge 19.96% premarket on $500K operating expense reduction in Q3 2025.

Milestone Scientific surged 20.0% in premarket trading following the release of its Q3 2025 earnings report, which highlighted a 23% year-over-year reduction in operating expenses ($500,000 cut) and stable revenue ($2.4 million). The company emphasized progress in operational restructuring, including enhanced international dental sales, growth in medical disposables recurring revenue, and advancements in Medicare reimbursement for its CompuFlo® system. These developments aligned with CEO Eric Hines’ remarks on building a “leaner, more focused organization,” reinforcing investor confidence in the company’s cost-discipline and strategic execution. While the resignation of a board member (Reason 2) and prior non-compliance notices were noted, the premarket rally was primarily driven by the positive operational and financial updates, which signaled improved margins and long-term value creation.